Claire Mazumdar insider trades

Open-market stock purchases and sales by Claire Mazumdar, Chief Executive Officer at Bicara Therapeutics Inc, from SEC Form 4 filings since Jun 9, 2025.

Recent trades

DateStockTradeValue
Aug 10, 2026BCAX Bicara Therapeutics IncSold$280K
Aug 10, 2026BCAX Bicara Therapeutics IncBought (not open market)$37.9K
Aug 10, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Jul 10, 2026BCAX Bicara Therapeutics IncSold$283K
Jul 10, 2026BCAX Bicara Therapeutics IncSold$831
Jul 10, 2026BCAX Bicara Therapeutics IncBought (not open market)$37.9K
Jul 10, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Jun 9, 2026RLAY Relay Therapeutics, IncBought (not open market)—
May 18, 2026BCAX Bicara Therapeutics IncSold$240K
May 18, 2026BCAX Bicara Therapeutics IncSold$60.6K
May 18, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Apr 20, 2026BCAX Bicara Therapeutics IncSold$354K
Apr 20, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Apr 16, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Apr 16, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Apr 16, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 20, 2026BCAX Bicara Therapeutics IncSold$30.2K
Mar 20, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 19, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 19, 2026BCAX Bicara Therapeutics IncSold$130K
Mar 18, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 18, 2026BCAX Bicara Therapeutics IncSold$122K
Mar 9, 2026BCAX Bicara Therapeutics IncSold$705K
Mar 9, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 6, 2026BCAX Bicara Therapeutics IncSold$71.6K

Companies traded

  • BCAX Bicara Therapeutics Inc: 17 sales, last Aug 10, 2026
  • RLAY Relay Therapeutics, Inc: other filings, last Jun 9, 2026

Get free alerts when Claire Mazumdar files a new trade →